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ABSTRACT 
 
 
This study was performed to test the viability of administering a single 40 mg 
dose of Folltropin-V® (FSH, Bioniche Animal Health) diluted in SRF (MAP-5 50, 
Sodium Hyaluronate, Bioniche Animal Health) on day 5 of a recipient synchronization 
protocol to beef cows to evaluate its effect on recipient fertility. All recipients were 
administered an estradiol 17 (2.5 mg, IM) and progesterone (50 mg, IM) combination 
injection on day 0 and a CIDR® (progesterone 1.34 g, Pfizer Animal Health) was 
inserted. Lutalyse® (dinoprost tromethamine, Pfizer Animal Health, 25 mg, IM) was 
administered at the time of CIDR removal on day 7, and estradiol 17 (1 mg, IM) was 
administered on day 8. On day 16, the presence of at least one corpus luteum (CL), 
detected via ultrasound, resulted in the recipient receiving an embryo (both fresh and 
frozen-thawed embryos were used). Embryos were not transferred into cows that did not 
show the presence of a CL. Dependent variables for which data were collected included 
circulating progesterone levels at the time of transfer, number of CLs and CL diameter, 
circumference, and area; measured in millimeters. The study (n=572) consisted of a 
treatment group (n=268) and a control group (n=304), and included both Bos indicus 
(Brahman influenced) crossbred (n=115) and Bos taurus (Angus based) cows (n=457). 
Pregnancy rates for Treated recipients (40.67%A) and Control recipients (52.96%B) 
differed (P<.05). There was no difference in the mean number of CLs per recipient for 
Treated (1.14 + .03) and Control (1.10 + .02) cows, nor was there a difference in 
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progesterone (P4) at the time of transfer for Treated (3.14 + .40 ng/mL) and Control 
(3.23 + .18 ng/mL) recipients. Overall, the inclusion of Folltropin-V® diluted in 
hyaluronan in a FTET synchronization protocol did not improve the fertility of beef 
recipients.   
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CHAPTER I 
INTRODUCTION AND REVIEW OF LITERATURE 
Introduction 
 Historically, the beef industry has overcame many obstacles to establish itself as 
one of the leading protein providers, yet as we emerge into the 21st century, the task of 
maintaining production with fewer resources than ever presents a formidable challenge. 
Models predict the world population to reach 9.5 billion by 2050 and in turn a 70% 
increase in world food production will be required to feed the populace (Keyzer et al. 
2005). Progress has certainly been made in the last few decades, as the industry is able to 
produce 1 billion kg of beef with less than 69.9% of the total animal numbers, 81.4% of 
the available feedstuffs, 87.9% of the water resources, and 67% of the land that was 
available in 1977 (Capper, 2011). Still, a likely increase in meat consumption is 
forecasted as incomes begin to rise (Keyzer et al., 2005), yet the beef industry will have 
to also improve inefficiencies at all levels in order to still be able to compete with the 
vertically integrated pork and poultry industries. Management of beef cattle will need to 
be heavily researched to refine methods of production with reduced resources available. 
One potential answer may be more rapidly advancing the genetic merit of beef herds and 
employing stringent selection and culling practices. To date, the most efficient way to 
maximize production from genetically superior beef cows is through the use of advanced 
reproductive techniques, specifically embryo transfer (ET).  
 Embryo transfer has been steadily increasing in popularity since its initial 
commercial use in the 1970s, especially in the last decade, as the American Embryo 
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Transfer Association reports that in 2002 3.6% (5,105) of registered angus calves were 
developed through ET, yet by 2007 that figure had risen to 11.5% (40,000) (Lamb and 
Black, 2011). It’s estimated that annually over 500,000 embryos are transferred globally, 
with around 200,000 of those transfers taking place in the United States (AETA, 2009). 
Though over the last four decades ET breakthroughs have included the adoption of non-
surgical techniques, reliable cryopreservation and thawing methods, embryo splitting, 
embryo sexing, in-vitro methods, and cloning, actual efficiency of these methods in 
terms of offspring produced has not progressed nearly as much (Hasler, 2010). In 
America, as of 2006, the average number of recipients pregnant out of those that 
received an embryo is 62.4% for fresh embryos and 56.9% for frozen (AETA, 2009).) In 
an attempt to quantify what percentage of the time the inability of a live calf to develop 
is due to recipient factors or when pregnancy loss is a result of embryo factors, 
McMillan et al., 1998 developed a statistical model that utilized a binomial distribution 
to measure such responsibilities. The authors determined that beyond day 60 of the 
pregnancy, in almost all cases, the embryo is the determinant for pregnancy loss, 
however, prior to the day 60 benchmark, the recipient is mostly at fault. Though the 
exact amount is hard to measure, it is clear that whether or not an embryo develops full 
term is highly dependent upon the uterine environment and many physiological aspects 
of the recipient, including fertility, nutritional plane, body condition, age, health, parity, 
and post-partum period (Lamb and Black, 2011). To test their model, McMillan et al., 
1999 identified a group of recipients who had a high propensity to carry their embryo to 
the 60 day mark and a group of recipients that had a low propensity to carry their 
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embryo to the same day. By examining when the greatest variation in the percentage of 
females in each group were pregnant the authors were able to determine that the majority 
of ET pregnancies that do not result in a live calf are occurring early on, within 25 days 
of the transfer, indicating “the critical period”, or days 15-17 when maternal recognition 
of pregnancy occurs are appropriately named. Prior to this work, much of the early 
research primarily focused on superovulation techniques and the donor, yet it has been 
shown that a large percentage of the inefficiencies is due to the recipient, which the 
maintenance of happens to be the most expensive part of an ET protocol (Looney, 2006; 
Hinshaw, 1999). Though more studies are needed, success has been seen utilizing 
several hormonal treatments to not only synchronize the recipient with the donor, which 
alone greatly improves pregnancy rate (Spell et al., 2001), but improve fertility. It is 
necessary to both improve recipient cow management as well as further develop 
protocols to improve pregnancy rate in order for continued expansion of this technology 
beyond the purebred sector and ultimately to help support the future of the beef industry.  
Recipient Selection and Management 
 For every recipient that fails to become pregnant, there is an estimated loss of 
$100 in drugs and time (Looney, 2010), thus selecting the right females to become 
recipients, and properly managing them, is critical. Though there is much debate on what 
traits are significant when it comes to selecting recipients, most practitioners and 
producers agree that recipients must be highly fertile, possess calving ease, and have the 
ability to raise a quality calf (Lamb et al., 2001) and that females who have a history of 
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either cystic ovaries, retained placenta, and/or poor lactation records should be avoided 
(Stroud and Hasler, 2006). Perhaps the most effective purchasing method of recipients is 
to buy pregnant cows, calve them out, and palpate for reproductive soundness, and then 
no sooner than 60 days utilize them as recipients (Stroud and Hasler, 2006).  
 One of the most beneficial aspects of managing recipients is the employment of a 
synchronization protocol of which some practitioners would call the most significant 
advancement in the ET field of the last 15 years (Looney et al., 2005). Recipients’ estrus 
should be synchronized with that of the donor within (+ ) 24 hours in order to avoid a 
reduction in pregnancy rate (Hasler, 2001, Spell et al., 2001). It is also imperative that 
recipients receive their embryo between days 6 and 8 of the synchronization protocol 
(Hasler, 2001). 
It was discovered in the 1940s that exogenous progesterone, primarily produced 
by a functional CL, would delay estrus in sheep and cattle (Looney et al., 2005). 
Subsequent studies primarily focused on shortening the luteal phase through the use of 
prostaglandin and progesterone (Looney et al., 2005).  Therefore, initial treatments for 
synchronization primarily included the administration of PGF2a with the understanding 
that the prostaglandin would regress the CL (Odde, 1990). Estrus detection was required 
for at least 5 days post PGF2a administration. Nonetheless, as technology and research 
advanced it became clear that there were inefficiencies with this protocol that needed to 
be corrected as variability in estrus detection and other factors led to only approximately 
50% of treated recipients being determined suitable for transfer (Bo et al., 2012). 
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Suitability of the recipients for transfer, which has remained the standard even in most 
current practice methods, is synchronization with the donor and the presence of a 
functional CL at the time of transfer (Looney et al., 2005). Currently, estrus detection 
has been eliminated from most protocols utilized. Fixed-timed embryo transfer (FTET) 
protocols vary dependent upon practitioner preference and government laws and 
regulations, as many drugs including equine chorionic gonadotropin and estradiol are not 
legal in some countries (Lamb and Black, 2011), however, the most common and 
effective protocol developed to date utilizes a combination of estradiol and progesterone 
as these two steroid hormones allow for the most controlled suppression of follicular 
growth of the dominant follicle and consistently induce a new follicular wave 2 to 3 days 
post ovulation (Looney et al., 2005). FTET protocols have been shown to have similar 
conception rates as estrus detection protocols for both heifers (Lamb, 2000) and cows 
(Bo et al., 2012), plus the FTET protocols actually increase overall pregnancy rates 
because a larger percentage of potential recipients actually receive an embryo (Looney et 
al., 2005).    
Fertility of beef cattle has been shown to be correlated to age, especially in 
females who are greater than 10 years old, where a major drop off in fertility occurs 
(Renquist et al., 2005). However, opinions vary on whether heifers or cows of less than 
10 years of age are more effective recipients. Heifers have been shown to have similar 
pregnancy rates as parous cows (Hasler, 2001; Benyei et al., 2006), yet the conception 
rates for pre-pubertal heifers and pubertal heifers, 36% vs. 76% respectively, are 
significantly different (Stroud and Hasler, 2006). Besides the obvious benefits of 
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utilizing heifers who have undergone puberty, it is also recommended that they have a 
pelvic area of 140 cm2 or greater at 12 months of age in order to more effectively avoid 
dystocia (Lamb et al., 2011). 
 Nutritional plane and body condition can have a major impact on beef cow 
fertility, mainly due to its direct connection with cyclicity, both with lactating and non-
lactating cows. It is well known that cows must establish maintenance and lactation prior 
to becoming reproductively functional (Short and Adams, 1988). Not surprisingly, 
condition and nutrition are major factors in recipient management as well. It has been 
determined that a moderate body condition score (BCS) is the most desirable for 
recipients at the time of transfer (Mapletoft, 1986). It is also highly important that 
recipients do not go through a negative energy deficit during the first 45 days after ET 
(Stroud and Hasler, 2006). Sufficient forage containing both adequate protein and energy 
levels are essential to the maintenance of recipient pregnancies, a fact often overlooked 
in poorly managed operations (Stroud and Hasler, 2006). This intermediate BCS (~6 on 
a scale of 1-9, ~3-3.5 on a 1-5 scale) is also important prepartum to ensure a timely 
return to estrous, as postpartum infertility is almost exclusively due to anestrous (Short 
et al, 1990). An increase in late gestation nutrition, in cows that have an intermediate 
BCS, is also associated with a shortened postpartum period (Jones and Lamb, 2008), as 
well as an increase in conception and pregnancy rate (Wiltbank et al., 1962). Anestrous 
multiparous cows, even utilizing a FTET protocol, have been shown to have much lower 
conception rates even though they may exhibit signs of estrous following treatment 
(Stroud and Hasler, 2006).  
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 In regards to lactation status, as with age, there is no industry-wide standard as to 
whether lactating or non-lactating recipients are more desireable. Perhaps the greatest 
benefit of utilizing lactating recipients is that they were recently reproductively 
competent to raise a calf. However, in most cases cows do not return to cyclicity, with 
all other limiting factors status quo, earlier than 45 days postpartum (Short et al., 1990). 
In the dairy industry, significant issues arise with utilizing lactating females as recipients 
due to the rate of metabolism of progesterone by the liver (Wiltbank et al., 2011) but 
limited literature is available about the rate of P4 matabolism in lactating beef cattle. 
One study, Meyer, 2002 via review by Looney et al., 2005, did show no significant 
difference in first service pregnancy rates of recipients whether they were lactating or 
not,  43.4% vs. 43.3%, respectively. 
 Though some have been discussed, there are a number of factors that can cause a 
recipient to unsuccessfully become pregnant. Beyond lack of proper synchronization, 
nutrition, recipient age, and improper embryo development, it is also important to note 
that calm handling practices of the recipients can improve conception rates as well. 
Studies have shown that stress and nervousness can cause infertility in beef cattle 
(Adams and Lamb, 2008). This can be induced by comingling cattle just prior to 
transfer, which has adverse effects on the established hierarchal status of the group 
(Lamb, 2011). When transferring, it is imperative that the females are secure in the 
squeeze chute in a comfortable fashion and not free to move to avoid nervousness 
(Stroud and Hasler, 2006). 
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Embryo Factors 
 From an experimental design standpoint, it is also important to limit the number 
of factors that are outside the scope of the study that could affect results. The embryo 
itself can also play a significant role in the success of an ET program. Two major 
reviews were published in 2001, Hasler, 2001 and Spell et al., 2001, that evaluated the 
factors that affected pregnancy rates in ET. From their results, fresh embryos resulted in 
a pregnancy a greater percentage of the time versus frozen embryos with Hasler, 2001 
finding the average number of recipients pregnant out of the number transferred to be 
68.3% in a sample size of over 9,000. From the same study, frozen embryos were 
reported to result in a sustained pregnancy 58.4% of the time. The same advantage for 
fresh vs. frozen was reflected in Spell et al, 2001, where results were 82.9% and 69%, 
respectively. 
 Industry wide, it is generally accepted that stage 4-6 embryos are the most 
successful in ET. Both reviews also showed positive benefits to utilizing stages 4 
(morulla) and 5 (early blastocyst) embryos versus stage 6 (blastocyst), though only the 
results from Hasler, 2001 were significant. In terms of embryo quality, on a scale of 1-3 
with 1 being excellent, grades 1 and 2 embryos had no significant difference in 
pregnancy rate in either study, however grade 3 embryos reported a significantly lower 
pregnancy rate in Hasler, 2001.    
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Follicular and Luteal Function as Related to Fertility 
 A major cause for embryonic loss is the inability of the corpus luteum (CL) to 
produce enough progesterone to prepare the endometrium for embryo implantation and 
maintenance of pregnancy (Looney, 2010). It’s been reported that a larger preovulatory 
follicle may generate a larger CL that will secrete more progesterone, and thereby have a 
positive effect on pregnancy (Binelli et al., 2001). The notion that the size of the 
preovulatory follicle dictates the size of the CL is further reinforced by Echternkamp et 
al., 2009 and Vasconcelos et al., 2001. Echternkamp et al., 2009 also concluded that 
progesterone levels correlated positively with ovulation rate and number of subsequent 
CLs. Along with this, the authors determined conception rates were higher for cows with 
multiple ovulations. 
 Traditionally, the estrous cycle of bovine consists of two to three follicular waves 
(Bo et al., 2003), with three to six follicles undergoing growth throughout each wave 
(Fortune et al., 2001). It’s been reported that preovulatory follicles are smaller in GnRH 
induced ovulations, and subsequently, there is a negative impact on fertility (Perry et al., 
2005). Even though GnRH is replaced with estradiol/progesterone in some fixed-timed 
embryo transfer protocols, Looney et al., 2010 states there is still concern amongst 
practitioners that the resulting CL(s) are smaller, especially in Bos indicus cattle who 
traditionally have smaller CLs as it is. One possible answer to this issue is to not induce 
ovulation until the preovulatory follicle grows into a persistant follicle by extending the 
implantation time period of a CIDR to 14 days (Mantovani et al., 2005). In AI, persistant 
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follicles have compromised conception rates, due to the extended age of the oocyte, 
however in ET protocols the recipients oocyte does not matter (Wherman et al., 1997). 
Even with elevated levels of progesterone however, conception rates to ET were not 
improved in recipients who had persistent follicles. Mantovani et al. 2005 actually found 
the conception rates to be lower (59.1% in control vs. 38.9% and 37.1% in treated 
groups) though there was a greater transfer rate in recipients with persistent follicles 
(51.4% in control vs. 77.4% and 74.6% in treated groups) as well as increased plasma 
progesterone rates (2.3 + .2 in control vs. 3.8 + .2 and 3.8 + .3 in treated groups).      
Importance of Progesterone in Establishing and Maintaining Pregnancy  
 Progesterone (P4), the hormone associated with pregnancy, is produced primarily 
by the corpus luteum and metabolized by the liver (Wiltbank et al., 2011). The amount 
of progesterone circulating in the body is correlated to the amount of luteal tissue present 
(Echternkamp et al., 2009, Wiltbank et al., 2011), however, inadequate levels of P4 are 
generally a result of a high rate of metabolism resulting from elevated blood flow. 
Amount of circulating progesterone present is directly related to the conceptus’ ability to 
produce bovine interferon-tau (bIFN-), which is the primary regulator of pregnancy 
recognition (Mann et al., 1999).  
 Throughout a large portion of the estrous cycle, P4 levels are peaked and 
inhibiting the increase of other hormones, and throughout this time, the uterine 
environment is very similar in both pregnant and non-pregnant females (Binelli et al., 
2001). A default prostaglandin (PGF2α) secretion system is in place; meaning that 
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unless PGF2α production is blocked, luteolysis will occur at approximately day 16, 
which is deemed the “critical period” as this is the turning point for the body to either 
“reset” and go through estrus or maintain a pregnancy. If conception does indeed occur, 
it is important for the conceptus to occupy the majority of the uterine horn ipslateral to 
the CL and that bIFN- production from the trophectoderm of the conceptus is adequate 
to block luteolysis. bIFN-, a 172 amino acid protein, acts on the uterine epithelium to 
prevent the pulsatile secretions of PGF2α that induce the regression of the CL (Bazer et 
al., 1994). Exactly how bIFN- prevents prostaglandin secretions isn’t entirely known. 
Bazer et al., 1994 provides four possible answers; 1) the up-regulation of endometrial P4 
receptors and prevention of E2 or Oxytocin receptors from forming on the endometrium; 
2) direct inhibition of E2 from generating PGF pulses; 3) direct inhibition of endometrial 
Oxytocin production; 4) inhibition of post-receptor mechanisms which prevent Oxytocin 
from releasing pulses of PGF. 
It is important to note that mortality of the conceptus up to and through the 
critical period is the most prevalent cause of fertility loss in cattle (Maurer et al., 1985). 
Due to its importance in the maintenance of pregnancy, P4 supplementation has been 
researched since the 1950s (Wiltbank et al., 2011), including its use in recipient 
protocols. It’s been reported that P4 treatments on days 3-6 prior to embryo transfer on 
day 7 resulted in longer embryos on day 14, just prior to the critical period (Clemente et 
al., 2009). Previous research in sheep found that recipient ewes that were treated with 
supplemental progesterone were capable of taking older embryos that were more 
elongated at the time of transfer (Garret et al., 1988). 
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Supplemental Gonadotropins and Other Treatments to Increase Fertility 
 With the commonly used FTET synchronization protocol that utilizes either a 
progesterone-estradiol combo or GnRH administration on day 0, a progesterone 
releasing intravaginal device for seven days and concurrent prostaglandin 
administration, there has been significant amounts of research worldwide involving the 
inclusion of an additional gonadotropin treatment to this protocol. The idea behind this is 
the added gonadotropin will help induce the growth of secondary follicles that will 
eventually ovulate and provide additional corpora lutea. Another theory is that the 
dominant follicle will benefit from supplemental gonadotropin and eventually ovulate 
and result in a larger CL and ultimately increase circulating progesterone. The elevated 
progesterone has multiple benefits on fertility but primarily has been shown to reduce 
early embryonic loss (Lopez-Gaitus et al., 2004).  
Equine Chorionic Gonadotropin (eCG) has been used in this role frequently in 
South America and in various countries internationally. eCG is a glycoprotein 
gonadotropin that consists of two noncovalently linked peptide chains; a 96 amino acid 
alpha subunit and a 149 amino acid beta subunit (Murphy and Martinuk, 1991). eCG has 
a half-life that is rather long for most hormones, 40 hours, and to many researchers this 
extended half-life in conjunction with its similar characteristics to FSH and LH is the 
reasoning behind its beneficial effects on maintaining pregnancy (Baruselli et al., 2011). 
According to Bo et al. 2011, 400 IU of eCG on either day 5 or 8 is the most common 
way to increase pregnancy rates in South America. Utilizing this protocol, it is common 
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to see a transfer rate of 75-85% and pregnant/transferred rates typically exceeding 50% 
(Bo et al 2002). South American eCG trials (Nasser et al, 2004, Bo et al, 2011, Mayor, 
2008) are not the only ones to find the treatment beneficial to fertility, as similar results 
have been observed in China (Remillard et al., 2006) and Mexico (Looney et al., 2010). 
On the contrary, Small et al. 2007 and Pinheiro et al, 2008 found no significant 
difference in pregnancy rates. Despite the conflicting research, it is apparent that in most 
cases eCG appears to benefit the fertility of recipients, however, eCG is not FDA 
approved and therefore is not legal for use outside of research in the United States. 
Because eCG binds to FSH receptors in most mammals other than the horse (Murphy 
and Martinuk, 1991), and its strong FSH-like action, it has been hypothesized that FSH 
may have similar effects as eCG in FTET protocols. FSH, which also is a glycoprotein 
consisting of two polypeptide chains, an alpha and a beta, is traditionally administered 
exogenously to stimulate follicular growth and super-ovulate donors (Demoustier et al., 
1988). Mixed results have been reported in regards to the utilization of FSH in this role. 
Martins et al., 2010 reported anestrous Bos Indicus cows that were treated with 10 mg of 
Folltropin-V® on day 8 of a FTAI protocol had a similar ovulation rate to that of cows 
treated with 300 IU eCG (85.5% vs. 82.5%) at the same time. Not surprisingly, 
pregnancy rates were also similar in the two groups; 51.4% for the FSH group and 
55.9% for the eCG group. For both ovulation rate and pregnancy rate a control group 
that received no additional treatment was significantly lower; 71.8% and 38.9% 
respectively. However, in two other separate Fixed-Timed Artificial Insemination 
(FTAI) studies, no significant increase in fertility was observed using supplemental FSH 
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(Sa Filho et al., 2009, Sales et al., 2011). Follicular growth also was shown to not be 
advanced by the administration of supplemental FSH (Sales et al., 2011). A potential 
reason behind the lack of benefit in fertility in some cases may be due to the short half-
life of FSH (Sa Filho, 2009), which can range from 5 to 12 hours (Demoustier et al, 
1988). Interestingly, FSH has been reported to have similar benefits on fertility as eCG 
in FTET (Zanenga et al., 2010). The authors found that a day 8 injection of 10 mg FSH 
(Folltropin-V®) resulted in a transfer rate of 72.6%, pregnant/transferred rate of 49.2%, 
and a pregnancy rate of 35.7%. 400 IU of eCG administered on the same day for a 
second group of heifers resulted in a transfer rate of 87.3%, a pregnant/transferred rate of 
43.5%, and a pregnancy rate of 35.7%, with only the difference in transfer rate being 
significant. In a second trial, both 10 mg and 20 mg doses were tested against 400 IU of 
eCG with results being similar; with respective transfer rates being 76.8%a, 83%ab, and 
89.5%b, conceptions rates of 39.7%a, 39.7%a, 38.8%a, and pregnancy rates of 30.5%a, 
32.9%a, and 34.7%a. Again, only transfer rates were significantly different.        
One potential downfall to the repeated use of eCG treatments is the buildup of 
antibodies to eCG and subsequent decline in added benefit to fertility (Drion et al., 
2001). Bos taurus cattle appear more likely to buildup antibodies than Bos indicus 
(Mantovani et al., 2010).  
Slow Release Formula Folltropin®-V 
Traditionally, superovulation in bovine includes either a once daily 
administration of eCG or twice daily administration of Porcine FSH (pFSH) for four 
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days. The extended half-life of eCG allows for fewer animal handlings than the pFSH 
protocol and obtaining optimal superovulation of the donors while further reducing 
stress on the animal and possibility of injury to both humans and the donor is also 
desirable.  
Folltropin®-V (Bioniche Animal Health, Bogart, GA) reconstituted with a slow 
releasing formula (SRF), consisting of reduced concentrations of Hyaluron (HA) and 
administered in a two shot protocol has been shown to have similar effects on super-
stimulatory response as a traditional 8 shot protocol (Hasler and Hockley, 2012). Tibulo 
et al., 2011 also showed that a similar number of transferrable embryos and 
corresponding CL size were generated with a one time intramuscular injecton of FSH in 
HA vs. a 8 shot protocol. HA is a biodegradeable polymer of disaccharides (i.e. 
glycosaminoglycan) and is found in the mammalian uterus, connective, epithelial and 
neural tissues, and has an extended half-life in relation to FSH diluted with saline 
(Looney and Pryor, 2012). Along with its potential benefits in superovulation, HA can 
also be useful in culture media as it has the ability to elevate the viscosity of the media 
and regulate water distribution and binding to the cell (Looney and Pryor, 2012). Finally, 
a third potential use for FSH may be as a carrier for pFSH but utilized in the recipient 
synchronization protocols as discussed in the previous chapter. 
Reproductive Differences in Bos taurus and Bos indicus Cattle   
 Though primarily only found in significant numbers in the gulf coast region of 
the United States, Bos indicus cattle are dominant in South America and tropical regions, 
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where most of the world’s cattle population resides (Baruselli et al., 2004). Hot 
temperatures, humidity, and extensive populations of ectoparasites can hinder the 
performance of most Continental and British cattle, yet Bos taurus derived breeds such 
as the Brahman and Nellore appear to thrive in these conditions. There also appears to be 
slight reproductive differences between the two types of cattle as Bos indicus tend to 
have a shorter duration of estrus, a higher incidence of silent estrus, and commonly show 
signs of estrus only at night (Looney et al., 2010). Bos indicus also have longer 
gestations than Bos taurus with the average time period being 292 days (Looney et al., 
2005). Following calving, Bos indicus cattle have longer postpartum periods and 
durations of anestrous (Sales et al., 2011), which is the main factor negatively affecting 
reproductive performance (Baruselli et al., 2004). Ruiz-Cortes, 1998 reported an average 
time period for cyclicity to return to normal in Bos indicus cows of 217 -278 days, 
extending the calving interval to 17-19 months. Not to mention, Brahmans and Brahman 
crosses have been reported to have smaller CLs than do Bos taurus, and subsequently 
have lower circulating progesterone (Randel et al., 2005).  
 In regards to FTET synchronization protocols and treatments, it is also important 
to note that Bos Indicus appear to be more sensitive to FSH (Barros and Noguera, 2001). 
Most cattle, throughout the estrous period have two to three follicular waves emerge 
before a dominant follicle is selected, matured, and ovulated (Sartori et al., 2010). 
However, there is a much higher incidence of four waves and even five waves observed 
in Bos indicus (Bo et al, 2003) (Sartori et al., 2010). Each wave in Bos taurus cattle 
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consists of approximately 24 small (2 to 5mm) antral follicles (Ginther et al., 1996), yet 
in Bos indicus, up to 50 antral follicles have been reported (Buratini Jr et al., 2000).  
 Interestingly, Saldarriaga et al., 2006 and Zuluaga et al., 2006 both report that the 
Co-synch with a CIDR protocol is much less effective in Bos indicus cross females as 
opposed to straight Bos taurus. In an attempt to solve this problem, Pack et al., 2005 
replaced the GnRH with Estradiol Benzoate (EB) and reported results of 91% of Bos 
indicus females having new follicular wave emergence compared to 53% in Bos taurus. 
Looney et al., 2010 utilized a protocol involving a progesterone and estradiol benzoate 
combination administered on day 0, CIDR for 7 days, PGF concurrent with removal and 
EB on day 8, and reported a transfer rate of 89% and pregnancy rate of 53%.  
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CHAPTER II 
DEVELOPING A FIXED-TIME EMBRYO TRANSFER PROTOCOL WHICH 
INCLUDES FOLLICLE STIMULATING HORMONE SLOW RELEASE FORMULA 
Introduction 
 Follicle stimulating hormone (FSH) is produced by the anterior pituitary and in 
conjunction with luteinizing hormone (LH) is responsible for the selection and growth of 
oocytes during diestrus. In embryo transfer, supplemental FSH is typically given to a 
donor female in successively decreasing doses over a 2-4 day period, primarily to induce 
multiple oocyte production/ovulations and ultimately increase the production of a 
genetically superior female.  
 It has been hypothesized that due to the increase in luteal tissue formed from 
cows that have been superovulated (SOV), there are potential benefits to supplementing 
FSH into recipient synchronization protocols to increase progesterone production, and 
ultimately increase fertility. There has been reported success of international studies that 
included equine chorionic gonadotropin (eCG) in recipient protocols (Bo et al., 2011), 
yet eCG is not approved for use in the United States. eCG has FSH-like action when 
administered to recipients, thus supplemental FSH could potentially increase the fertility 
of recipients as well.  
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Materials and Methods 
 The data of this study was collected in collaboration with OvaGenix, LP, a 
private embryo transfer company located in Bryan, TX. All cattle were provided by 
customers of OvaGenix, LP and the cost of materials and labor were funded by Bioniche 
Animal Health (Bogart, GA). Recipients included in the study (n=572) were located on 
ranches in Texas and Oklahoma and consequently were managed under slightly differing 
climate conditions. Nutrition, age, and health can all play a substantial role in the fertility 
of the recipients (Lamb, 2011), however, the author, ranch owner and ET practitioner all 
agreed that recipients utilized in the study were of good health, acceptable age (parous, 
<8 years old), and nutritional plane was suitable to maintain a body condition score of 4-
7 (on a 1-9 scale). Nonetheless, in order to minimize the skewedness of data due to 
environmental and forage conditions, this study was carried out over two separate 
seasons; the fall of 2011 and spring of 2012. Ranches in the fall study included Goudeau 
Livestock (Wharton,TX), Suzi Q Angus (Center, TX), 714 Ranch Angus (Nacogdoches, 
TX), Pollard Angus (Enid, OK), Howdy U Cattle (Bagwell, TX), and Collier Farms 
(Chappell Hill, TX). Ranches included in the spring study included Howdy U Cattle 
(Bagwell, TX), Kiamichi Link Ranch (Antlers, OK), Heritage Cattle Co. (Wharton, TX), 
Forgason Cattle (Wharton, TX), Pollard Angus (Enid, OK), and Goudeau Livestock 
(Wharton, TX). Due to drought-like conditions in the summer of 2011 forage levels 
during the fall study on the ranches involved in the study were poorer than during the 
spring study. Late winter rainfalls improved the forage conditions prior to the spring 
study.     
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The objective of this study was to determine the effectiveness of including a 40 
mg injection of Folltropin-V® (IM, Bioniche Animal Health, Bogart, GA) diluted in 
hyaluronan on day 5 of a FTET synchronization protocol to increase fertility of the 
recipients. Recipients included in the study were randomly placed in either the Treated 
or Control groups, with the Treated group having the day 5 injection of FSH included in 
their synchronization protocol. The estrous cycles of all the recipients, both Treated and 
Control, were synchronized using a progesterone-estradiol based protocol (outlined in 
Figure 1.) that included a day 0 injection of estradiol 17 (2.5 mg, IM) and progesterone 
(50 m, IM) combination, a CIDR® (1.34 mg, Pfizer Animal Health) was also inserted at 
this time and removed 7 days later. Concurrent with CIDR removal recipients were 
administered Lutalyse® (dinoprost tromethamine, Pfizer Animal Health, 25 mg, IM), 
and then on day 8 were administered estradiol 17 (1 mg, IM). On day 16, the presence 
of at least one functional corpus luteum, detected via rectal ultrasound, resulted in the 
recipient receiving an embryo. Both fresh and frozen embryos were utilized. Embryos 
were not transferred into cows that did not show ultrasonic evidence of a CL. 
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Figure 1.  Timeline of the recipient synchronization protocol with day 5 FSH SRF 
injection included (Treated group protocol) 
 
A 40 mg dose was chosen due to the results of an unpublished pilot study 
performed by the author and Ovagenix, LP, of which the results are displayed in Table 1. 
Most notably, the number of recipients with multiple CLs appeared to favor treated 
recipients, though the results of the study were never formally analyzed with SAS. The 
number of cows that received an embryo did not vary much between the groups, 
however of those that did receive an embryo, the cows treated with a 40 mg dose of FSH 
fared the best. From the results it also appeared that the 20 mg treatement was not nearly 
as effective as the 40 mg dose, and thus the 20 mg dose was not included in the present 
study.  
 
 
 
 
 
 
Estradiol
CIDR Removal + PGF
Day 0  Day 
FSHProg./Estr. Combo + CIDR  Transfer
1675 8
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Table 1.   Fertility data in beef recipients following synchronization for fixed‐time 
embryo transfer with a protocol that included (Treated) 40 mg, 20 mg or did 
not include (Control) FSH in hyaluronan 
        
Group  N  No. 
Transferred 
No. 
Pregnant 
Preg./Prog.  Pregnancy 
Rate 
% Recips with 
Mult. CL 
40 mg  23  17  12  12/17 (71%)  12/23 (52%)  7/17 (41.18%) 
20 mg  23  18  8  8/18 (44%)  8/23 (35%)  2/18 (11.11%) 
Control  29  24  14  14/24 (58%)  14/29 (48%)  1/24 (4.17%) 
Total  75  59  34  34/59 (57.6%)  34/75 (45.3%)  10/59 (16.95%) 
 
 
The present study consisted of grade cows of Bos taurus (n=457) and Bos indicus 
crossbred (n=115) breed composition. Breed type was proportionally distributed in each 
group, with the Treated group (n=268) consisting of 53 Bos indicus crossbred and 215 
Bos taurus cows. The Control group (n=304) consisted of 62 Bos indicus crossbred cows 
and 242 Bos taurus cows. The author both collaborated with the owners and visually 
appraised the recipients to determine their breed type. Females that appeared to be 50% 
or greater Bos indicus blood were classified as Bos indicus crossbreds. All other 
recipients were classified as Bos taurus. The primary breed type of the Bos indicus 
crossbred recipients was F1 Hereford X Brahman crosses, and all recipients in the Bos 
taurus classification were Angus based.  
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Other independent variables for which data was collected consisted of; body 
condition score (BCS, 1-9 scale), postpartum interval, and lactation status. A total of 206 
lactating cows (103 Treated; 103 Control) and 366 dry cows (165 Treated; 201 Control) 
were included in the study. A breakdown of the lactation status and number of Bos 
indicus and Bos taurus in each group for the Treated and Control groups is presented in 
Table 2.      
 
  Table 2.  Breed type and lactation status of recipients in the 2011 fall study and 2012 
spring study by group; Treated (40 mg FSH SRF) or Control 
 
  N  Bos Taurus 
(Lactating) 
Bos Taurus     
(Dry) 
Bos Indicus 
(Lactating) 
Bos Indicus    
(Dry) 
Fall Treated  122  34  50  11  27 
Fall Control  152  31  66  7  48 
Spring 
Treated 
152  61  84  4  3 
Spring 
Control 
146  48  83  10  5 
Total    174  283  32  83 
 
 
Due to the fact that clientele of OvaGenix, LP, were the providers of recipients 
for the study, as opposed to university owned livestock, scheduling conflicts did arise in 
regards to the date of the additional FSH SRF injection. At the advice of the ET 
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practitioner a small number of recipients received the injection of the additional FSH 
SRF on day 3 (n=35), day 4 (n=72) and day 6 (n=23), in addition to those who received 
the injection on day 5 (n=165).   
 Ranch personnel were responsible for administering the recipients with the day 0 
combo shot, CIDR insertion and removal, and the lutalyse and estradiol injections. The 
additional injection of FSH SRF to the Treated group was administered by the author. 
The FSH SRF was injected using 3 mL syringes with 18 gauge 1.5 inch needles and 
administered intramuscularly in the lower quarter of the recipient. The transfer of 
embryos into recipients was performed by ET practitioners employed by OvaGenix, LP. 
In the Treated group, 118 fresh embryos and 78 frozen embryos were transferred and in 
the Control group 164 fresh embryos and 100 frozen embryos were transferred. Fresh 
embryos were grades 1 and 2, and frozen embryos were all grade 1. Only embryos that 
were stage 4, 5, and 6 were utilized. Thawing of frozen embryos was performed 
following the guidelines described in the IETS manual, as well as Hasler, 2011.    
Ultrasounding was performed by OvaGenix, LP, personnel, using a SonoSite 
MicroMaxx® (Sonosite Inc., Bothell, WA) with a 7mm rectal imaging probe. Split-
screen images of each ovary of the recipients who received an embryo were stored and 
the author used the on-screen caliper calculation measuring tool to measure the CL 
diameter, area, and circumference. Other dependent variables for which data was 
collected included number of CLs, plasma progesterone levels at the time of transfer, 
pregnancy status, transfer rate (no. cows transferred/no. of cows synchronized), 
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conception rate (no. cows pregnant/ no. cows transferred), and pregnancy rate (no. cows 
pregnant/ no. cows synchronized). To determine plasma progesterone (P4), whole blood 
(approximately 5-8 mL) was drawn from all recipients that which an embryo was 
transferred to on day 16, at the time of transfer. Samples were extracted via tail bleeding, 
and immediately placed on ice. Within 24 hours, all blood samples were inverted for 
mixing and then centrifuged for 20 minutes at 3,300 rpm at a temperature of 5C. Blood 
plasma was extracted and stored in 1.5 mL microcentrifuge tubes at -20C. All plasma 
samples were then assayed for P4 using radioimmunoassay (RIA) procedures (Abraham 
et al., 1971). For the spring study, the low pool and high pool coefficients of variation 
(CV) for the assays were .73 and 12.05%, respectively. For the fall study, the low pool 
and high pool CV were 3.47 and 9.79%.      
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CHAPTER III 
RESULTS 
Results of Overall Study 
 Transfer rate, pregnant/transferred rate, and pregnancy rate results are presented 
in Table 3. Transfer rates and pregnancy rates of the Treated and Control groups were 
significantly different (P < .0001, and P < .0006, respectively), while conception rates 
were not (P > .1590).  
 
Table 3.  Transfer rate, pregnant/transferred rate, and pregnancy rate of recipients  in 
the Treated and Control groups 
 
  No. 
Programmed 
No. 
Transferred 
No. 
Pregnant 
Transfer 
Rate 
Preg./Trans. 
Rate 
Pregnancy 
Rate 
Treated  268  196  109  73.13%A 55.61%  40.67%A
Control  304  264  161  86.84%B  60.98%  52.96%B
Total  572  460  270  80.42%  58.70%  47.20% 
ABDiffering superscripts denote a difference (P<.05) 
 
  In total, 48 cows had multiple ovulations during the experiment, resulting 
in multiple CLs. The mean number of CLs per cow and breakdown of the number of 
cows within each group that had multiple CLs is presented in Table 4. There was no 
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significant difference in the mean number of CLs per cow nor the percentage of cows 
within the group who had multiple CLs between the Treated and Control groups.   
 
Table 4.   Number of recipients with multiple corpora lutea and mean number of CLs 
per cow in the Treated and Control groups 
 
  No. Cows  Mean No. CL 
Treated  22/196 (11.22%)  1.14 + .03 
Control  25/264 (9.47%)  1.10 + .02 
Total  47/460 (10.44%)  1.12 + .02 
  
 
CL diameter, circumference, area per CL, and total luteal area means are 
presented in Table 5. Differences in circumference, area per CL, and total luteal area did 
not differ between the two groups, however mean diameter was significantly different 
between the two groups ( P < .004).  
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Table 5.   Mean (+SEM) CL diameter, circumference, area per CL, and total luteal area 
per cow  
 
  No.  Diameter 
(mm) 
Circumference 
(mm) 
Area per CL 
(mm2) 
Total Luteal 
Area per cow 
(mm2) 
Total Treated  196  17.07 + .32A 53.09 + .93 23.76 + .68  26.23 + .84
Total Control  263  18.32 + .29B 56.21 + .67 24.94 + .52  27.36 + .74
Total  459  17.79 + .22 54.88 + .56 24.44 + .42  26.87 + .56
ABDiffering superscripts denote a difference (P<.05) 
 
 At the time of transfer blood samples were taken and radioimmunoassayed for 
serum progesterone, with results being shown in Table 6. The mean circulating 
progesterone level, presented in ng/mL, of recipients within the Treated and Control 
groups were not significantly different. 
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Table 6.   Mean (+ SEM) circulating progesterone (P4) for recipients at the time of 
transfer for the Treated and Control groups 
 
   No.  Mean P4 (ng/mL) 
Treated  189  3.14 + .40 
Control  251  3.23 + .18 
Total  440  3.18 + .20 
 
 
Correlation coefficients between continuous variables for which information was 
collected are provided in Table 7. Of note, there is only a slight correlation between total 
luteal area and P4. Expectedly, number of CLs was correlated with mean total luteal area 
and negatively correlated with mean CL diameter, circumference, and area. Number of 
CLs nor mean total CL area were significantly correlated with mean circulating P4 at the 
time of transfer.  
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Table 7.   Correlation values of continuous variables collected on recipients 
Pearson Correlation Coefficients 
Prob > |r| under H0: Rho=0 
  Mean P4  No. of CLs   Mean CL Diameter 
Mean CL 
Circumference
Mean CL 
Area 
Mean 
Total 
Luteal 
Area 
Mean P4    .01201 .8007 
‐.03628 
.4462 
‐.01388 
.7708 
.08357 
.0789 
.09521 
.0452 
No. of CLs  .01201 .8007   
‐.14748 
.0015 
‐.13197 
.0046 
‐.15975 
.0006 
.46687 
<.0001 
 
 
Lactation Status 
 Treated cows that were lactating had a significantly lower pregnancy rate 
(36.97%A) than both lactating (52.24%B) and non-lactating (54.37%B) control recipients. 
The pregnancy rate of treated cows that were non-lactating was intermediate (46.60%). 
However, both treated lactating and non-lactating recipients had a significantly lower 
transfer rate than control lactating and non-lactating recipients. None of the groups 
differed in pregnant/transferred rate. Detailed results are presented in Table 8. No 
significant difference was determined in CL measurements between lactating and non-
lactating recipients (Table A1.). Though lactating recipients tended to have higher 
amounts of circulating progesterone than non-lactating recipients, the difference was not 
significant (Table A2).  
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Table 8.  Transfer rate, pregnant/transferred rate, and pregnancy rate of recipients by 
lactation status in the Treated and Control groups 
 
  No. 
Programmed 
No. 
Transferred 
No. 
Pregnant 
Transfer 
Rate 
Preg./Trans.  Pregnancy 
Rate 
Treated 
Lact. 
165  118  61  71.52%A  51.69%  36.97%A 
Treated 
Non‐Lact. 
103  78  48  75.73%A  61.54%  46.60% 
Control Lact.  201  174  105  86.57%B  60.69%  52.24%B 
Control Non‐
Lact. 
103  90  56  87.38%B  65.12%  54.37%B 
Total  572  460  270  80.42%  58.70%  47.20% 
ABDiffering superscripts denote a difference (P<.05)  
 
Breed 
 Pregnancy/transferred rate and pregnancy rate for Bos taurus control recipients 
differed from Bos taurus treated, Bos indicus crossbred treated and control groups. Both 
treated Bos taurus and Bos indicus crossbred cows differed from Bos taurus and Bos 
indicus crossbred control cows. Full transfer, pregnancy/transferred, and pregnancy rates 
are shown in Table 9. 
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Table 9.   Transfer rate, pregnant/transferred rate, and pregnancy rate of Bos taurus 
(BT) and Bos indicus crossbred (BIX) cows in the Treated and Control groups 
 
   No. 
Programmed 
No. 
Transferred 
No. 
Pregnant 
Transfer 
Rate 
Preg./Trans.  Pregnancy 
Rate 
BT 
Treated 
215  159  92  73.95%A  57.86%A  42.79%A 
BIX 
Treated 
53  37  17  69.81%A  45.95%AB  32.08%A 
BT 
Control 
242  207  138  85.54%B  66.67%C  57.02%B 
BIX 
Control 
62  57  23  91.94%B  40.35%B  37.10%A 
Total  572  460  270  80.42%  58.70%  47.20% 
             
 ABCDiffering superscripts denote a difference (P<.05) 
 
Number of cows with multiple CLs and the mean number of CLs per cow did not 
differ by breed and treatment (Table A3). Bos taurus treated cows did differ in CL 
diameter and circumference than Bos taurus control and Bos indicus control recpients, 
however mean area per CL and total luteal area did not differ amongst the groups (Table 
A4).  
Table 10 shows the mean circulating progesterone levels at the time of transfer 
for Bos indicus crossbred and Bos taurus cows. Bos taurus Treated cows and Bos taurus 
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Control cows differed from both Treated and Control Bos indicus crossbred but did not 
differ with one another. 
 
Table 10.   Mean (+ SEM) circulating progesterone (P4) at the time of transfer of Bos 
taurus (BT) and Bos indicus crossbred (BIX) cows in the Treated and Control 
groups 
 
   No.  Mean P4 (ng/mL) 
BT Treated  152  2.82 + .35A 
BIX Treated  37  4.48 + .56B 
BT Control  194  2.64 + .31A 
BIX Control  57  5.26 + .45B 
Total  440  3.19 + .20 
ABDiffering superscripts denote a difference (P<.05) 
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Injection Day 
Results in regards to transfer rate, conception rate, and pregnancy rate are further 
explained in Table 11. Recipients injected on day 6 had a significantly higher pregnancy 
rate than Day 3, Day 4, and Day 5 treated recipients, however Day 6 did not differ from 
the other days in pregnancy/transferred rate and pregnancy rate. Day 4 treated recipients 
differed from day 5 treated recipients in pregnancy rate. Day 6 treated recipients did not 
differ from the other days, but did record the highest pregnancy rate.   
 
Table 11.  Transfer rate, pregnant/transferred rate, and pregnancy rate of recipients in 
the Treated group by day of the synchronization protocol that they received 
FSH‐SRF 
 
   No. 
Programmed 
No. 
Transferred 
No. 
Pregnant 
Transfer 
Rate 
Preg./Tran.  Pregnancy 
Rate 
Day 3  35  20 14 57.14%A 70.00%B  40.00%
Day 4  72  51 22 70.83%AB 43.14%A  30.56%A
Day 5  138  103 62 74.64%B 60.19%B  44.93%B
Day 6  23  22 11 95.65%C 50.00%  47.83%
Total  268  196 109 73.13% 55.61%  40.67%
     
ABCDiffering superscripts denote a difference (P<.05) 
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 The number of cows with multiple CLs and the mean number of CLs per cow for 
each injection day are shown in Table 12. Day 5 treated recipients differed from the 
other days in mean number of CLs. 
 
Table 12.   Number of recipients with multiple corpora lutea and mean number of CLs 
per cow by injection day in the Treated group 
 
Injection Day  N  Mean No. CLs 
Day 3  0/20 (0.0%)  1.00 + .09A 
Day 4  5/46 (10.87)  1.10 + .05A 
Day 5  16/103 (15.53%)  1.21 + .04B 
Day 6  1/21 (4.76%)  1.05 + .08A 
Total  48/460 (10.44%)  1.12 + .02 
ABDiffering superscripts denote a difference (P<.10) 
 
  Mean circulating progesterone appeared to be higher in days 5 and 6 treated 
recipients versus days 3 and 4 treated recipients, though only days 5 and 4 differed. Full 
results of circulating progesterone by injection day are shown in Table 13. 
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Table 13.   Mean (+ SEM) circulating progesterone (P4) for recipients at the time of 
transfer for cows in the Treated group by day of the synchronization protocol 
that they received FSH‐SRF 
 
   No.  Mean P4 (ng/mL) 
Day 3  20  1.82 + 1.26 
Day 4  51  1.91 + .81A 
Day 5  103  3.88 + .55B 
Day 6   22  3.52 + 1.18 
Total  189  3.14 + .40 
ABDiffering superscripts denote a difference (P<.05) 
 
Season 
Transfer rates, conception rates, and pregnancy rates, broken down by season and 
treatment group are shown in Table 14. Treated recipients from the spring were 
significantly lower for pregnancy rate but actually had the highest pregnant/transferred 
rate, though none of the groups differed.  Both fall and spring treated recipients were 
significantly lower for transfer rate.   
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Table 14.    Transfer rate, pregnant/transferred rate, and pregnancy rate of recipients in 
the Treated and Control groups by season 
 
   No. 
Programmed 
No. 
Transferred 
No. 
Pregnant 
Transfer 
Rate 
Preg./Tran.  Pregnancy 
Rate 
Fall 
Treated 
122  95  57  77.87%A  60.00%  46.72%B 
Spring 
Treated 
146  128  81  69.18%A  63.28%  35.62%A 
Fall Control  152  131  80  86.18%B  61.07%  52.63%B 
Spring 
Control 
152  101  52  87.50%B  51.49%  53.29%B 
Total  572  455  270  79.55%  59.34%  47.20% 
ABDiffering superscripts denote a difference (P<.05) 
 
Table 15 shows the mean circulating progesterone levels at the time of transfer. 
Fall Control and spring Control cows differed, with fall control recipients being 
significantly greater. 
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Table 15.   Mean (+ SEM) circulating progesterone (P4) at the time of transfer of 
recipients in the Treated and Control groups by season  
 
   No.  Mean P4 (ng/mL) 
Fall Treated  94  3.43 + .43 
Spring Treated  95  2.87 + .43 
Fall Control  127  3.98 + .37A 
Spring Control  124  2.47 + .38B 
Total  440  3.19 + .20 
ABDiffering superscripts denote a difference (P<.05) 
 
Mean CL measurements by season and treatment group are depicted in Appendix 
Table 5. Mean CL diameter measurements of Control cows from the spring portion of 
the study differed from spring Treated, fall Control, and fall Treated cows. Spring 
Treated and fall Treated cows also differed for mean CL diameter. Spring Treated cows 
differed from the other three classifications for mean CL circumference. Spring Treated 
and Spring Control cows differed in mean area per CL. Spring Treated cows also 
differed from fall treated and fall Control cows in total luteal area per cow.  
The number of cows with multiple CLs by season and treatment group and the 
mean number of CLs per cow are shown in Table 16. Both fall treated and fall control 
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tended to be higher than spring treated and spring control classifications though only fall 
treated differed. 
 
Table 16.    Number of recipients within the Treated and Control groups with multiple 
corpora lutea and the mean number of CLs per cow 
 
 
 
 
 
 
 
 
 
    
ABDiffering superscripts denote a difference (P<.05) 
 
Other Independent Variables 
 Included in Table 17 are the P-values for the effect of other independent 
variables, for which data was collected, on pregnancy rate of the recipients. Only body 
condition score tended to have an effect (P < .10). 
 
 
  No. of cows with 
multiple CLs 
Mean No. of CLs per 
cow 
Fall Treated  15/94 (15.96%)  1.22 +.04B 
Spring Treated  7/95 (7.37%)  1.07 + .04A 
Fall Control  18/127 (14.17%)  1.15 + .03 
Spring Control  8/124 (6.45%)  1.06 + .03A 
Total  48/460 (10.44%)  1.12 + .02 
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Table 17.  The effect of post‐partum interval of the recipients prior to the initiation of 
the synchronization protocol, body condition score of the recipients, and 
whether a fresh or frozen embryo was transferred on the overall pregnancy 
rate of the recipients.   
 
Variable  P-Value 
Post‐Partum Interval  .7601 
Body Condition Score  .0660 
Fresh vs. Frozen Embryo  .5547 
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CHAPTER IV 
DISCUSSION 
Discussion of Overall Study 
  The intention behind administering supplemental FSH to the recipients was to 
increase circulating progesterone in the ET recipients by inducing multiple ovulations 
and increasing subsequent luteal tissue. Day 5 was chosen as the timing of 
administration for the FSH in order to maximize the effect, as this time period is 
synonymous with the first follicular wave emergence. During follicular wave 
emergence, prior to the selection of a dominant follicle, FSH is especially important to 
the development of the emerging follicles (Mihm and Bleach, 2003). Thus, we 
hypothesized that the FSH would stimulate more follicular growth prior to the follicles 
switching from FSH-dependency to LH-dependency, and in turn, generate multiple 
ovulations. A similar approach with eCG being utilized instead of FSH has shown 
positive results in many international studies (Bo et al., 2011).  
 The hypothesized advantage in fertility of recipients who received FSH diluted in 
hyaluronan versus control cows proved to be false in the present study as pregnancy 
rates for Treated and Control cows were 40.67% and 52.96%, respectively. However, 
previous studies that included supplemental FSH given to recipients on day 8 of a 
synchronization protocol had pregnancy rates of 35.7%, 30.9%, and 32.9% (Zanenga et 
al., 2010). The higher pregnancy rate of treated cows in the current study compared to 
those of the aforementioned studies may be attributed to the fact that the FSH was 
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diluted in hyaluronan thus lengthening the half-life of the hormone within the body.  
Transfer rates and pregnant/transferred rates of the current study followed these same 
trends of being in line or slightly above those of related studies, yet control cows 
appeared more fertile, with the difference being significant for transfer rate and 
pregnancy rate.  
 The authors also hypothesized that the inclusion of FSH diluted in Hyaluronan 
would increase both the size of each corpus luteum and number of CLs, due to the 
enlarged preovulatory follicle, and subsequently we would see a higher mean 
progesterone value at the time of transfer on day 16 of the protocol. Nonetheless, no 
significant difference was observed in mean CL circumference, area, and total luteal are 
per cow. CL diameter did differ between the two groups but the control cows had the 
larger CL diameters. The means for both groups were in line with those of previous 
studies of recipients who did not receive any additional gonadotropins in their 
synchronization protocol. (Echternkamp et al., 2009). However, they CL measurements 
appeared to be slightly lower than those in eCG trials (Bo et al., 2011). For instance, 
Peres et al., 2011 via Bo et al., 2011 review, found 400/736 recipients treated with eCG 
had CLs with diameters greater than 18 mm. In regards to CL numbers, the findings of 
the present study (Table 2) were intermediate with eCG trials. In two studies, Nasser et 
al., 2004 reported the mean number of CLs possessed by eCG treated recipients to be 
1.36 and 1.35.However, in a study with a much larger sample size, Peres et al., 2011 via 
Bo et al., 2011 review, found that eCG treated recipients had a mean number of CLs of 
1.10.  
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 Though the means didn’t differ significantly, Control cows did have a slightly 
higher amount of circulating progesterone at the time of transfer. Our means, 3.14 + .40 
for Treated cows and 3.23 + .18 for Control cows, were similar to P4 means found in 
Mantovani et al., 2005, Pfeiffer et al., 2008, Carter et al., 2008, Pursley and Martins, 
2012.   
 Due to numerous findings in published literature that stated a correlation between 
luteal tissue and progesterone output, the author created Table 7, to show the strength of 
the correlation between P4 and the various CL measurements that were recorded. There 
did appear to be a correlation between mean total luteal area per cow and progesterone, 
though the correlation was not strong (.09521). Also of note, from our study it appeared 
that as the number of CLs increased, there was a negative correlation to size of the CLs. 
Lactation Status 
 Lactation status of the recipients has not been heavily researched in regards to 
FTET, but one known study, Meyer, 2002 via Looney et al., 2005 review, reported that 
lactation status did not affect pregnancy rate of recipients. In the present study, perhaps 
the variable is confounded with other variables, such as owner and management, because 
CL number, size, and P4 did not differ between lactating and non-lactating recipients, 
regardless if they were in the Treated or Control group.  
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Breed 
Table 9 shows the differences in transfer rate, pregnant/transferred rate, and 
pregnancy rate for the recipients by treatment and breed. Bos taurus recipients appeared 
to be much more fertile than the Bos indicus Due to the findings reviewed in Bo et al., 
2003, it was hypothesized that the mean diameter of CLs in the Bos indicus recipients 
would be smaller than those of the Bos taurus cows. Subsequently, due to the correlation 
between CL diameter and P4 in previous research, we expected lower average 
circulating progesterone in the Bos indicus females due to less luteal tissue being 
present. It was also believed that the Bos indicus recipients would be more sensitive to 
the FSH, and perhaps show a greater response to the treatment by generating either 
larger CLs or a greater number of CLs.  
From Appendix Table 4, the mean diameter of Bos indicus cows was not lower 
than the Bos taurus females. Interestingly, the mean diameter reported for the treated and 
control Bos indicus cows was in line with the mean diameters reported in Bo et al., 2003. 
However, the Bos taurus cows in the present study tended to have CL diameters lower 
than those reported in Bo et al., 2003. However, the lower mean diameter of the Bos 
taurus appeared to not affect pregnancy rate as the control Bos taurus group was 
significantly higher than the Bos taurus treated and Bos indicus control and treated 
groups.  
Contrasting with the statements in Bo et al., 2003, the present study found there a 
significant difference in the circulating progesterone levels of Bos indicus and Bos 
 45 
 
taurus females, with the Bos indicus cows reporting much higher means, as described in 
Table 10. Our results are more in line with the findings of Bastos et al., 2010 via Sartori 
et al.,2010 review, which reported higher progesterone concentrations in Bos indicus 
cows versus Bos taurus. Though mixed results have been reported and more research is 
required, it may be plausible that Bos indicus cows metabolize estradiol and 
progesterone more slowly than do Bos taurus. 
The findings in the present study also contrast much literature that states higher 
progesterone levels at the time of transfer are positively correlated with pregnancy rate, 
as Bos indicus recipients, both Treated and Control, had higher P4 levels than Bos 
Taurus but had lower pregnancy rates than Bos taurus recipients. 
Injection Day 
 Day 5 of the synchronization protocol was chosen as the time period when the 
FSH would be administered to the recipients due to the concurrency with the first 
follicular wave of the estrous cycle. However, the author was forced to alter the protocol 
in certain instances due to scheduling conflicts with the ranches that owned the 
recipients, therefore data was collected on recipients who received the FSH injection on 
days 3, 4, 5, and 6. From Table 11, though only day 5 and day 4 treated recipients 
differed in pregnancy rate, it appears those recipients who received the injection on days 
5 or 6 fared better in regards to pregnancy rate, though sample sizes varied significantly. 
Interestingly, day 5 recipients differed from the recipients treated on the other days in 
number of CLs, which certainly implies that the timing of our intended treatment may 
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have positive benefits on generating accessory CLs. This is also validated by the fact that 
day 5 treated recipients differed for circulating progesterone. Day 5 treated recipients 
also differed for number of CLs per cow, 1.21 + .04, which is in line with most 
published eCG research, as referenced earlier in the literature review chapter.  
 However, it should also be of note that the data compared in regards to injection 
date may be confounded with other unforeseen independent variables, such as 
management/ownership and location. Recipients were not randomized as to the date 
when they received the FSH and as such, all of the day 3 recipients were owned by 
Kiamichi Link Ranch while all of the recipients that were treated on day 6 were also all 
owned by Howdy U Cattle Co. Both ranches also had recipients who were treated on 
different days within the study as well.  
 In order to provide an accurate comparison of the day 3 and day 6 treated 
recipients while under common management, Table 18 shows the comparison in 
pregnancy rate, total luteal area, and circulating progesterone at the time of transfer of 
these two ranches recipients.  
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Table 18.  Comparison of transfer rate, pregnant/transferred rate, and pregnancy rate, 
as well as mean total luteal area and mean P4 at the time of transfer for 
Kiamichi Link Ranch recipients and Howdy U Cattle Co. recipients 
 
  Howdy U               KL Ranch 
Season  Spring  Fall Spring Spring
Injection Day  4  6 3 4 
No. Programmed  30  23 35 32 
No. Transferred  22  22 19 19 
No. Pregnant  14  11 14 5 
Transfer Rate  83.33%  95.65% 57.14% 65.63%
Preg./Trans. Rate  56.00%  50.00% 70.00%B 23.81%A
Pregnancy Rate  46.67%  47.83% 40.00%B 15.63%A
Mean Total Luteal 
Area 
24.80 + 2.33 30.43 + 2.48 25.43 + 2.61 21.92 + 2.54
Mean P4  1.51 + .83  3.52 + .83 1.82 + .89 1.35 + .89
ABDiffering superscripts denote a difference (P<.05) 
 
From Table 18, there appears to be no conclusive connection between injection 
day and pregnancy rate. Not surprisingly, the group with the largest mean total luteal 
area also had the highest circulating progesterone mean, reaffirming the findings of 
Binelli et al., 2001.  
Season 
The present study was carried out over two separate breeding seasons, in part to 
offset management and nutritional variables that could have impacted the study. Data 
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was essentially analyzed as a 2 x 2 factorial with season (spring vs. fall) and treatment 
group (Treated vs. Control). The author was unable to find any published literature that 
looked at the effectiveness of FTET based on the season, and from the finding of the 
present study it is unclear whether seasonal factors had an effect on fertility of the 
recipients. It appeared Treated recipients from the spring fared the worst in pregnancy 
rate (Table 14) and also generated the least amount of total luteal area (Appendix Table 
5). The only consistent pattern observed was that fall Treated recipients appeared to 
generate a greater number of CLs per cow.  
Seasonal data was analyzed more thoroughly in an attempt to explain the results. 
As previously mentioned, the pregnancy rates of the treated cows were significantly 
lower than those of the control cows, but from Table 14 it is clear that those cows that 
were treated in the spring were especially lower than those in the fall. Table 19 below 
shows data for recipients from each ranch that had cows included in the spring portion of 
the study.  
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Table 19.  Transfer rate, pregnant/transferred rate, pregnancy rate, mean total luteal area, and mean P4 for each of the ranches 
in the spring study  
 
 
 
 
 
 
  Pollard  Howdy U  KL Ranch  Heritage  Forgason 
  Treated  Control  Treated  Control  Treated  Control  Treated  Control  Treated  Control 
No. 
Prog. 
30  15  30  44  67  83  9  6  10  4 
No. 
Tran. 
22  15  25  42  41  67  8  5  5  4 
No. 
Preg. 
11  12  14  26  19  39  5  3  3  3 
Transfer 
Rate 
73.33%  100.00%  83.33%  95.45%  61.19%  80.72%  88.89%  83.33%  50.00%  100.00 
Preg./ 
Tran. 
Rate 
50.00%  80.00%  56.00%  61.90%  46.34%  58.21%  62.50%  60.00%  60.00%  75.00% 
Preg. 
Rate 
36.67%  80.00%  46.67%  59.09%  28.36%  46.99%  55.56%  50.00%  30.00%  75.00% 
Mean 
Total 
Luteal 
Area 
24.44 + 
3.06 
26.89 + 
2.07 
24.80 + 
1.57 
30.18 + 
1.49 
23.63 + 
1.17 
26.31 + 
1.14 
25.51 + 
3.96 
20.68 + 
5.00 
28.54 + 
7.74 
17.23 + 
4.58 
Mean 
P4 
2.34 + 
.34 
3.01 + 
.43 
1.51 + 
.23 
1.76 + 
.30 
1.58 + 
.21 
2.28 + 
.22 
12.33 + 
8.19 
6.50 + 
1.78 
5.81 + 
2.90 
4.33 + 
2.14 
 50 
 
From Table 19 it is clear that all ranches excluding Heritage Cattle Co. had a 
considerable decrease in pregnancy rate from control to treated groups. Pollard Farms, 
Howdy U Cattle Co., and Kiamichi Link also reported having larger mean total luteal 
area and a greater mean P4 value in control cows versus treated cows.  
Geographically, the ranches with cows in the spring portion of the study 
represented different regions, with Pollard Farms being located in northwest Oklahoma, 
Howdy U Cattle Co. in northeast Texas, Kiamichi Link in east Oklahoma, and Heritage 
Cattle Co. and Forgason Cattle Co. in south Texas. Cattle at all ranches were managed in 
large pastures, winter precipitation alleviated most drought conditions in these areas 
suggesting nutritional decline should have not been much of a negative influence on the 
fertility of the recipients. A decrease in fertility would have been observed 
proportionately between the control and treated groups if management or nutritional 
intake was at fault for the poor results, but it was primarily just the treated group that 
was negatively impacted. To fully understand the reasoning behind the results that were 
observed in this study, more research is required.  
It is well documented that FSH levels spike at the time of follicular wave 
emergence and exogenous FSH can cause co dominant (or more) follicle formation. 
However, as Fortune et al., 2001 explains, extended FSH may inhibit the dominant 
follicles ability to secrete estradiol and complete its maturation process. A more accurate 
understanding of metabolization of FSH diluted in hyaluronan is needed to understand if 
the hyaluronan caused the metabolization to be delayed too much.  
 51 
 
Other Independent Variables 
Table 17 offers the p-values for the effect of other independent variables for 
which data was collected and its effect on overall pregnancy rate. Only body condition 
score tended to have an effect, yet there is potential for this to be confounded with other 
variables due to the limited variability between BCS of 4 (n=122), 5 (n=310), and 6 
(n=108). 
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CHAPTER V 
CONCLUSIONS 
 Results from the present study indicate that administering FSH diluted in 
Hyaluronan on day 5 of a synchronization protocol is not a viable way to increase 
fertility of recipient cows. In fact, administering the slow-release FSH may have a 
negative impact on fertility, as pregnancy rates were significantly lower in the treated 
cows versus the control cows. The numerous variables, both dependent and independent 
make indentifying the cause of the lowered response in treated cows rather inconclusive. 
Due to the success of similar protocols that utilized eCG, as opposed to FSH, further 
work is needed to determine the correct conversion rate for the two supplemental 
gonadotropins, as well as timing of the dosage. To the best of our knowledge no other 
domestic studies have utilized FSH diluted in hyaluronan and thus we have no true 
comparison of our findings, but the author suggests repeating the study utilizing cows 
under common management so as nutrition and other unforeseen factors may not skew 
results.   
 Another factor to consider is that most work with eCG has been 
conducted with Nellore cattle in South America. The present study consisted of Brahman 
crossbred and Angus based cows. Breed differences in regards to sensitivity to 
gonadatropins, even within the Bos taurus and Bos indicus classifications, may exist but 
potentially are not as well understood.  
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Another adjustment to the experimental design of the current design that should 
be considered for future work is to take multiple blood samples to analyze the rate of 
metabolization of FSH diluted in HA. With multiple blood samples it would also be 
possible to determine if any increase or decreases in P4 due to treatment are sustained 
over a period of time.  
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APPENDIX 
 
Table A1.   Number of recipients with multiple corpora lutea and mean number of CLs 
per cow by lactation status in the Treated and Control groups 
 
  No.  Mean No. CL 
Treated Lact.  13/119 (10.92%)  1.15 + .04 
Treated Non‐Lact.  9/78 (11.54%)  1.13 + .04 
Control Lact.  13/174 (7.47%)  1.09 + .03 
Control Non‐Lact.  13/89 (14.61%)  1.15 + .04 
Total  47/460 (10.22%)  1.12 + .02 
 
 
 
Table A2.   Mean (+ SEM) circulating progesterone (P4) at the time of transfer of 
recipients by lactation status in the Treated and Control groups 
 
  No.   Mean P4 ng/mL 
Treated Lact.  115  3.46 + .39 
Treated Non‐Lact.  74  2.65 + .49 
Control Lact.  167  3.49 + .33 
Control Non‐Lact.  88  2.64 + .49 
Total  444  3.18 +.20 
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Table A3.   Number of recipients with multiple corpus lutea and mean number of CLs per 
cow by breed type in the Treated and Control groups 
 
  No.  Mean No. CL 
BT Treated  20/159 (12.58%)  1.15 + .03 
BIX Treated  1/37 (2.70%)  1.08 + .06 
BT Control  21/208 ((10.10%)  1.11 + .03 
BIX Control  5/56 (8.93%)  1.11 + .05 
Total  47/460 (10.22%)  1.12 + .02 
 
 
 
Table A4.  Mean (+ SEM) CL diameter, circumference, area per CL, and total luteal area 
per cow of Bos taurus (BT) and Bos indicus crossbred (BIX) cows in the 
Treated and Control groups 
 
   No.  Diameter 
(mm) 
Circumference 
(mm) 
Area per CL 
(mm2) 
Total Luteal 
Area per 
cow (mm2) 
BT Treated  159  16.88 + .37A  52.63 + .96A  23.52 + .70  26.23 + .88 
BIX Treated  37  17.88 + .72  55.03 + 1.76  24.77 + 1.48  26.17 + 2.43 
BT Control  207  18.17 + .33B  56.21 + .85B  24.99 + .62  27.22 + .78 
BIX Control  57  18.71 + .58B  56.04 + 1.43B  24.23 + 1.20  27.54 + 1.97 
Total  460  17.79 + .22  54.88 + .56  24.44 + .42  26.87 + .56 
ABDiffering superscripts denote a difference (P<.05) 
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Table A5.   Mean (+SEM) CL diameter, circumference, area per CL, and total luteal area 
per cow of recipients in the Treated and Control groups by season 
 
  No.  Diameter 
(mm) 
Circumference 
(mm) 
Area per CL 
(mm2) 
Total Luteal 
Area per 
cow (mm2) 
Fall Treated  95  16.35 + .46B  55.90 + 1.20A  24.43 + .91  28.07 + 1.22A 
Spring Treated  101  17.75 + .44C  50.44 + 1.16B  23.13 + .88B  24.49 + 1.19B 
Fall Control  130  16.88 + .39BC  56.34 + 1.03A  23.98 + .78  27.61 + 1.04A 
Spring Control  128  19.72 + .39A  56.01 + 1.04A  25.68 + .79A  26.96 + 1.05 
Total  454  17.79 + .22  54.88 + .56  24.44 + .42  26.87 + .56 
ABCDiffering superscripts denote a difference (P<.05) 
 
 
 
 
 
 
 
 
 
 
